Bottom line
CHTRX vs USRAX: the short answer
CHTRX (Invesco Charter Fund) and USRAX (Horizon Multi-Factor U.S. Equity Fund) share a meaningful slice of their top holdings — about 60% by weight.
But USRAX is far broader, holding 159 positions to 69 for CHTRX, so beyond the top names it adds exposure CHTRX doesn't have.
CHTRX is cheaper at 1.01% vs 1.02% — a difference of $1.00 a year per $10,000 invested.
Over five years, USRAX returned +12.2% a year vs +11.3% for CHTRX.
CHTRX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
CHTRX vs USRAX side by side
| CHTRX | USRAX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Invesco | Horizon |
| Category | Large Blend | Large Blend |
| Expense ratio | 1.01% | 1.02% |
| Annual cost per $10k | $101 | $102 |
| 10-yr cost on $10k (prospectus) | $1,718 | $1,248 |
| Max front load | 5.5% | — |
| 12b-1 fee | 0.25% | 0.1% |
| 1-yr return | +9.6% | +15.2% |
| 5-yr return (annualized) | +11.3% | +12.2% |
| 10-yr return (annualized) | +10.9% | — |
| Best quarter | +18.6% | +11.7% |
| Worst quarter | −20.6% | −18.8% |
| Net assets (fund) | $3.7B | $777.4M |
| Number of holdings | 69 | 159 |
| Portfolio turnover | 36% | 134% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | CHTRX | USRAX | Difference |
|---|---|---|---|
| 2025 | +15.9% | +15.2% | +0.7% |
| 2024 | +25.3% | +17.7% | +7.6% |
| 2023 | +23.0% | +15.0% | +8.1% |
| 2022 | −20.7% | −10.7% | −10.0% |
| 2021 | +27.4% | +27.5% | −0.1% |
| 2020 | +13.5% | +5.2% | +8.3% |
Source: Fund prospectus bar charts
Holdings overlap
14 of CHTRX's top 25 holdings also appear in USRAX's top 25.
| Holding | CHTRX | USRAX |
|---|---|---|
| NVIDIA Corp. | 8.51% | 5.40% |
| Alphabet Inc. | 6.78% | 5.86% |
| Microsoft Corp. | 6.65% | 5.26% |
| Apple Inc. | 6.22% | 5.67% |
| Meta Platforms, Inc. | 2.82% | 3.27% |
| Eli Lilly and Co. | 2.08% | 1.73% |
| Mastercard Inc. | 1.84% | 1.16% |
| Micron Technology, Inc. | 1.57% | 5.28% |
| Johnson & Johnson | 1.52% | 2.38% |
| Applied Materials, Inc. | 1.50% | 1.43% |
| Chevron Corp. | 1.42% | 2.04% |
| Philip Morris International Inc. | 1.38% | 0.79% |
| Procter & Gamble Co. (The) | 1.27% | 0.85% |
| Merck & Co., Inc. | 1.15% | 1.40% |
Source: SEC Form N-PORT
CHTRX top 10
- NVIDIA Corp. — 8.51%
- Alphabet Inc. — 6.78%
- Microsoft Corp. — 6.65%
- Apple Inc. — 6.22%
- Amazon.com, Inc. — 4.79%
- Broadcom Inc. — 3.67%
- JPMorgan Chase & Co. — 2.88%
- Meta Platforms, Inc. — 2.82%
- Advanced Micro Devices, Inc. — 2.11%
- Eli Lilly and Co. — 2.08%
USRAX top 10
- Alphabet Inc — 5.86%
- Apple Inc — 5.67%
- NVIDIA Corp — 5.40%
- Micron Technology Inc — 5.28%
- Microsoft Corp — 5.26%
- Berkshire Hathaway Inc — 4.07%
- Meta Platforms Inc — 3.27%
- Exxon Mobil Corp — 2.54%
- Johnson & Johnson — 2.38%
- Chevron Corp — 2.04%
FAQ
What is the difference between CHTRX and USRAX?
Which is cheaper, CHTRX or USRAX?
Should I own both CHTRX and USRAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.